Rare pulmonary diseases and pulmonary hypertension
PH in LAM and PLCH is uncommon but clinically relevant, particularly in advanced disease. While emerging therapies show promise, further research is needed to optimize management and improve patient outcomes.
Authors
- Davide Elia (ORCID: https://orcid.org/0000-0002-7440-4978)
- Sergio Harari (ORCID: https://orcid.org/0000-0001-8629-7391)
- Federico Tagariello (ORCID: https://orcid.org/0000-0002-8834-1859)
Institutions
- University of Milan (IT)
- MultiMedica (IT)
Publication Details
- Journal
- Current Opinion in Pulmonary Medicine
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1097/mcp.0000000000001188
- Primary Topic
- Tuberous Sclerosis Complex Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00